ClinicalTrials.gov
ClinicalTrials.gov Menu

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00006358
Recruitment Status : Completed
First Posted : May 26, 2004
Last Update Posted : July 24, 2008
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by:
National Cancer Institute (NCI)